Among the top-selected targets, we observed a statistically significant down-regulation of MAF in AD (FDR-adjusted P = 2.28 × 10−8; table S4B), a gene identified as an AD GWAS risk gene and a differentially expressed TF (12), regulated by SPI1. Here, SPI1 is linked to Alzheimer disease.